Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Cytokinetics Inc
About CYTK
Cytokinetics, Incorporated is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing muscle biology-directed drug candidates as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The Company is engaged in the commercialization of aficamten, a cardiac myosin inhibitor, and is being evaluated in additional clinical trials enrolling patients with obstructive and non-obstructive hypertrophic cardiomyopathy. The Company is also developing omecamtiv mecarbil, a cardiac myosin activator, in patients with heart failure with severely reduced ejection fraction (HFrEF); CK-586, a cardiac myosin inhibitor for the potential treatment of heart failure with preserved ejection fraction (HFpEF) and CK-089, a fast skeletal muscle troponin activator with potential therapeutic application to a specific type of muscular dystrophy and other conditions of impaired skeletal muscle function.
Find out what a historical investment in Cytokinetics Inc would be worth today using our CYTK stock calculator.
Market Capitalisation
$10.36B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.38M
High today
$79.12
Low today
$76.30
Open price
$77.08
52-week high
$80.20
52-week low
$29.81
Ready to start your investing journey with Stake?
Open an accountHow do I buy CYTK shares in Australia?
Buying CYTK shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Cytokinetics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CYTK
What is the ticker symbol of Cytokinetics Inc?
The ticker symbol for Cytokinetics Inc is CYTK.
How much is one share of CYTK?
One share of CYTK is valued at $78.71 as of 21 May 2026.
What is the market capitalisation of Cytokinetics Inc CYTK?
As of 21 May 2026 Cytokinetics Inc has a market cap of $10.36B.
What is the 52-week high for Cytokinetics Inc stock?
The Cytokinetics Inc 52-week high stock price is $80.20.
What is the 52-week low for Cytokinetics Inc stock?
The Cytokinetics Inc 52-week low stock price is $29.81.
Can I buy CYTK shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CYTK shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CYTK on Stake
- Buy CYTK from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CYTK from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CYTK related stocks